About me
Dr. Sarah Golding is dual qualified; both as a medical doctor and a biomedical scientist with honours in biochemistry and molecular biology. Her 12 years' experience at Australia's Therapeutic Goods Administration (TGA) include 9 years in the clinical review and approval of oncology and malignant haematology medicines. Dr Golding has been involved in Project Orbis since its inception and is a strong proponent of its benefits to patients. As part of an international panel at DIA, Dr Golding will share insights into the impact and challenges of Project Orbis from the perspective of a smaller regulator.
